期刊文献+

抗核基质蛋白2抗体阳性幼年特发性炎性肌病临床特征分析并文献复习

Clinical analysis and literature review of juvenile idiopathic inflammatory myopathy with positive anti-NXP2 antibody
原文传递
导出
摘要 目的探讨抗核基质蛋白2(NXP2)抗体阳性幼年特发性炎性肌病(JIIM)患者的临床表现及骨骼肌的病理特点和治疗。方法收集8例抗NXP2抗体阳性JIIM患者的临床资料, 回顾性分析其一般情况、临床表现、辅助检查、肌肉病理改变和治疗效果, 并结合国内外文献进行复习。结果 8例患者起病年龄为(6.1±3.8)岁, 男女比为1∶3;均出现四肢近端肌无力, 7例出现皮肌炎样皮疹, 5例出现肌痛, 4例出现皮肤钙质沉着, 3例出现皮肤溃烂, 2例出现皮下水肿, 1例出现腹痛症状。5例血清CK升高, 8例下肢肌肉磁共振显示肌肉, 肌肉间隙, 脂肪层异常信号, 3例胸部高分辨CT显示间质性肺炎改变, 1例腹部CT结果显示升结肠及近侧横结肠肠壁不规则增厚, 水肿, 伴周围炎性渗出。骨骼肌病理活检主要表现为束周肌萎缩, 束膜内、小血管周围及肌纤维间隙可见有炎性细胞浸润, 部分间质可见水肿、增生, 坏死、溶解及再生肌纤维少见。8例患者均给予糖皮质激素联合免疫抑制剂治疗, 1例合并肠道血管炎表现者联合使用戈利木单抗治疗, 随访6个月5例完全缓解, 3例恢复欠佳。结论抗NXP2抗体多见于幼年型皮肌炎中, 与肌无力、钙质沉着、皮肤溃疡和肠道血管炎有关, 骨骼肌病理改变相对轻微, 糖皮质激素联合免疫抑制剂治疗大部分有效。 Objective To investigate the clinical characteristics,muscle pathological features and treatment in patients with Juvenile idiopathic inflammatory myopathy(JIIM)with positive anti-nuclear matrix protein 2(NXP2)antibody.Methods The clinical data of 8 IMM patients with positive anti-NXP2 antibody were collected and the clinical manifestations,auxiliary examinations,muscle pathological changes and therapeutic effects were retrospectively analyzed.Results The ratio of male to female was 1:3.The median age of disease onset was(6.1±3.8)years.Eight cases had proximal muscle weakness,7 had dermatomyositis-like rash,5 had myalgia,4 had calcinosis,3 had skin ulcer,2 had edema and 1 had abdominal pain.Five cases had elevated serum creatine kinase.Eight cases with lower limb muscle MRI showed abnormal signals in muscle,space between muscles and fat tissue,3 cases with chest high-resolution CT(HRCT)showed interstitial lung disease.Abdominal CT of 1 case showed irregular thickening,edema and peripheral inflammatory exudation in ascending colon and proximal transverse colon.Pathological biopsy of skeletal muscle showed perifascicular atrophy,inflammatory cell infiltration in fascicular membrane and around small vessels and muscle fiber space.Edema,hyperplasia could be seen in interstitium;but dissolved necrosis,and regenerated muscle fibers were rarely seen.Treatments included glucocorticoids,immunosuppressive agents and biological agents(1 case).After 6 months of follow-up,5 cases had good outcomes and 3 cases had poor outcomes.Conclusion Dermatomyositis is the major clinical manifestation of idiopathic inflammatory myopathy with positive anti-NXP2 antibody.It is associated with myasthenia,calcinosis,skin ulcers and intestinal vasculitis.The pathological changes in skeletal muscle are relatively slightmild.Glucocorticoids combined with immunosuppressive agents are effective in most cases.
作者 程苏云 李丰 卫平 唐盈 谢颖 曾萍 曾华松 Cheng Suyun;Li Feng;Wei Ping;Tang Ying;Xie Ying;Zeng Ping;Zeng Huasong(Department of Pediatric Allergy,Immunology and Rheumatology,Guangzhou Women and Children's Medical Center,Guangzhou 510000,China)
出处 《中华风湿病学杂志》 CAS CSCD 2024年第3期184-189,I0003,共7页 Chinese Journal of Rheumatology
基金 国家自然科学基金(82271858) 广州市科技计划项目(2023A03J0902, 2024A03J0806) 广州市卫健委一般引导项目(20241A011027)。
关键词 肌炎 青少年 自身抗体 核基质相关蛋白质类 骨骼 Myositis Adolescent Autoantibodies Nuclear matrix-associated proteins Muscle,skeletal
  • 相关文献

参考文献2

二级参考文献16

  • 1Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory my?opathies myositis[J]. JAMA, 2011, 305: 183-190.
  • 2Oddis CV, Fertig N, Goel A, et al. Clinical and serological characterisation of the anti-MJ antibody in childhood myositis (abstract>[J]. Arthritis Rheum, 1997, 40: S139.
  • 3Targoff IN, Trieu EP, Levy-Neto M, et al. Sera with autoanti?bodies to the MJ antigen react with NXP2 (abstract)[J]. Arthritis Rheum, 2007, 56 Suppl 9: S787.
  • 4Mimura v. Takahashi K, Kawata K, et al. Two-step colocaliza?tion of MORC3 with PML nuclear bodies[J]. J Cell Sci, 2010, 123(PtI2): 2014-2024.
  • 5Y oshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies[J]. Autoimmunity, 2006, 39: 233-241.
  • 6Sato S, Hoshino K, Satoh T, et al. MDA5 (melanoma differen?tiation associated gene) as an autoantigen recognized by anti- CADM-140 antibody in patients with clinically amyopathic der?matomyositisf abstract Ilf]. Arthritis Rheum, 2008, 58: S923.
  • 7Espada G, Maldonado-Cocco JA, Fertig N, et al. Clinical and serologic characterization of an Argentine pediatric myositis co?hort: identification of a novel autoantibody (anti-MJ) to a 142- kDa protein[J]. J Rheumatol. 2009, 36: 2547-2551.
  • 8Gunawardena H, Wedderburn LR, Chinoy H, et al. Autoanti?bodies to a 140-kd protein in juvenile dermatomyositis are asso?ciated with calcinosis[J]. Arthritis Rheum, 2009, 60: 1807-1814.
  • 9Ishikawa A, Muro Y, Sugiura K, et al. Development of an EUSA for detection of autoantibodies to nuclear matrix protein 2[J].Rheumatology (Oxford), 2012, 51: 1181-1187.
  • 10Ceribelli A, Fredi M, Taraborelli M, et al. Anti-MJ/NXP-2 au?toantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis[J]. Arthritis Res Ther, 2012, 14: R97.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部